The idea of stem cell therapy is often over-simplified to mean taking donated cells and putting them in a patient to facilitate the treatment of a disease or injury. Its reality, though, is not as easy. Dr. Cameron Clokie asserts that regenerative medicine involves the use of utilized cells, molecules, and biomaterials to fix structures that are not functioning optimally due to injury or disease in the body.
The earliest known forms of cell therapy are blood transfusion and bone marrow transplantation. A patient can also have cell therapy through skin graft in cases of severe burns, where cells used are from the individual patient. Cell therapy is also known to better the quality of life of patients with chronic diseases. Since these discoveries, generative medicine has evolved with scientists coming up with new therapies. Read more: Dr. Cameron Clokie Gives His Quick Tips for Tooth Care While Traveling
Despite the many breakthroughs, only a few of these have made it to the patient, and it is disappointing that the number of regenerative medicine treatments is still low. The reason why new therapy has not materialized and patients are not benefiting much from the potential of regenerative medicine is attributed to the fact that generative medicine treatments are yet to become a mainstream medical practice in many fields of medicine. Learn more about Cameron Clokie: http://prairiesnewstribune.com/canada/toronto-dentist-cameron-clokie-talks-up-new-technology-available-to-oral-surgeons/3427
Also, generative medicine treatments are too expensive as they need special facilities and highly skilled team of staff. Since health budgets are insufficient in most countries, the high cost of production becomes a barrier.
Although there has been considerable progress in generative medicine, implementation of the research to practice is minimal. Dr. Cameron agrees that although there are many benefits to be reaped from generative medicine, its Implementation will remain limited due to its high cost.
Cameron Clokie is a maxillofacial and oral surgeon. He is also the chief executive officer of Induce Biologics Inc. The company is a regenerative medicine firm focusing on innovative solutions for musculoskeletal reconstruction.
Before retiring in 2017, Dr. Clokie was in academic dentistry and clinical practice. At Toronto University, he was named the Head of Oral and Maxillofacial Surgery in 1998. He was, at the time of retirement, a professor of Oral and Maxillofacial Surgery at the institution.